Referral and Treatment for Chronic Balanitis

Patients who suffer from chronic balanitis or recurrent episodes of the condition should be referred to a specialist for further evaluation and treatment. Recurrent balanitis can lead to phimosis, a condition where the foreskin becomes tight and difficult to retract, and in some cases, circumcision may be necessary to prevent further complications.

It is important to note that circumcision is not a direct medical treatment for other conditions, such as hypospadias. However, in some cases, circumcision may be required as part of hypospadias surgery to reconstruct the foreskin and improve the function of the penis.

Proper referral and treatment for chronic balanitis can help prevent further complications and improve the overall quality of life for patients.

After beginning a course of antibiotics, a child with scarlet fever is able to return to school after 24 hours. This particular girl displayed the typical symptoms and signs of scarlet fever, which is a notifiable disease that is treated with 10 days of penicillin V (or azithromycin for those with a genuine penicillin allergy, taken once a day for 5 days). Based on the clinical and immunisation history, it was less probable that the child had measles or rubella, both of which allow for a return to school 4 days after the rash appears. Children with whooping cough can also return to school under certain circumstances.

Scarlet fever is a condition caused by erythrogenic toxins produced by Group A haemolytic streptococci, usually Streptococcus pyogenes. It is more common in children aged 2-6 years, with the highest incidence at 4 years. The disease is spread through respiratory droplets or direct contact with nose and throat discharges. The incubation period is 2-4 days, and symptoms include fever, malaise, headache, sore throat, ‘strawberry’ tongue, and a rash that appears first on the torso and spares the palms and soles. Scarlet fever is usually a mild illness, but it may be complicated by otitis media, rheumatic fever, acute glomerulonephritis, or rare invasive complications.

To diagnose scarlet fever, a throat swab is usually taken, but antibiotic treatment should be started immediately, rather than waiting for the results. Management involves oral penicillin V for ten days, while patients with a penicillin allergy should be given azithromycin. Children can return to school 24 hours after starting antibiotics, and scarlet fever is a notifiable disease. Desquamation occurs later in the course of the illness, particularly around the fingers and toes. The rash is often described as having a rough ‘sandpaper’ texture, and children often have a flushed appearance with circumoral pallor. Invasive complications such as bacteraemia, meningitis, and necrotizing fasciitis are rare but may present acutely with life-threatening illness.

Fluoxetine as the Only Effective Medication for Treating Depression in Children and Adolescents

According to the British National Formulary (BNF), fluoxetine is the only medication that has been proven effective in clinical trials for treating depressive illness in children and adolescents. It is important to note that medication is not typically prescribed by non-specialists in this age group. However, as a healthcare provider, it is important to have a general understanding of any specialist-initiated treatments and investigations to be able to discuss them with patients.

The father has reported that the child experiences wheezing only during upper respiratory tract infections and not at any other time. This suggests that the child may not have asthma and instead may be experiencing viral-induced wheezing, which is common in children of this age.

Managing Asthma in Children: NICE Guidelines

The National Institute for Health and Care Excellence (NICE) released guidelines in 2017 for the management of asthma in children aged 5-16. These guidelines follow a stepwise approach, with treatment options based on the severity of the child’s symptoms. For newly-diagnosed asthma, short-acting beta agonists (SABA) are recommended. If symptoms persist or worsen, a combination of SABA and paediatric low-dose inhaled corticosteroids (ICS) may be used. Leukotriene receptor antagonists (LTRA) and long-acting beta agonists (LABA) may also be added to the treatment plan.

For children under 5 years old, clinical judgement plays a greater role in diagnosis and treatment. The stepwise approach for this age group includes an 8-week trial of paediatric moderate-dose ICS for newly-diagnosed asthma or uncontrolled symptoms. If symptoms persist, a combination of SABA and paediatric low-dose ICS with LTRA may be used. If symptoms still persist, referral to a paediatric asthma specialist is recommended.

It is important to note that NICE doesn’t recommend changing treatment for patients with well-controlled asthma simply to adhere to the latest guidelines. Additionally, maintenance and reliever therapy (MART) may be used for combined ICS and LABA treatment, but only for LABAs with a fast-acting component. The definitions for low, moderate, and high-dose ICS have also changed, with different definitions for children and adults.

If a patient is diagnosed with threadworms, also known as pinworms, it is recommended that all household contacts receive treatment, even if they do not exhibit any symptoms. Mebendazole should be taken by all family members on the same day, except for pregnant or breastfeeding women and children under 2 years old. Strict hygiene measures are advised for these exceptions to disrupt the life cycle of the worms. The adhesive tape test is preferred over a stool sample for lab testing confirmation, but in this case, it is not necessary as all household contacts should be treated. Permethrin is a topical insecticide used for treating scabies.

Threadworms: A Common Infestation Among Children in the UK

Infestation with threadworms, also known as pinworms, is a prevalent condition among children in the UK. The infestation occurs when individuals swallow eggs present in their environment. Although around 90% of cases are asymptomatic, some possible features include perianal itching, especially at night, and vulval symptoms in girls.

Diagnosis can be made by applying Sellotape to the perianal area and sending it to the laboratory for microscopy to see the eggs. However, most patients are treated empirically, and this approach is supported in the CKS guidelines.

The recommended management for threadworm infestation is a combination of anthelmintic with hygiene measures for all members of the household. Mebendazole is used as a first-line treatment for children over six months old, with a single dose given unless the infestation persists. By following these guidelines, individuals can effectively manage and prevent the spread of threadworms.

Newborns who are found to have bilateral undescended testes during their initial examination should be urgently reviewed by a senior paediatrician within 24 hours, as per the current guidelines from Public Health England. This is crucial as bilateral undescended testes may indicate underlying endocrine disorders or ambiguous genitalia, and early intervention can help prevent complications such as infertility, torsion, and testicular cancer.

It is not appropriate to monitor bilateral undescended testes in primary care, unlike unilateral undescended testes which may be monitored. Waiting for 4 months, 12 months, or 24 months is too long and can increase the risk of complications.

Arranging an ultrasound and waiting for the results is also not appropriate as it can take too much time. Urgent referral to a paediatrician is necessary to ensure timely diagnosis and management.

Undescended testis is a condition that affects approximately 2-3% of male infants born at term, but is more common in premature babies. Bilateral undescended testes occur in about 25% of cases. This condition can lead to complications such as infertility, torsion, testicular cancer, and psychological issues.

To manage unilateral undescended testis, it is recommended to consider referral from around 3 months of age, with the baby ideally seeing a urological surgeon before 6 months of age. Orchidopexy, a surgical procedure, is typically performed at around 1 year of age, although surgical practices may vary.

For bilateral undescended testes, it is important to have the child reviewed by a senior paediatrician within 24 hours as they may require urgent endocrine or genetic investigation.

If symptoms appear after formula is introduced, it strongly indicates the presence of cow’s milk protein intolerance.

Cow’s milk protein intolerance/allergy (CMPI/CMPA) is a condition that affects approximately 3-6% of children and typically presents in formula-fed infants within the first 3 months of life. However, it can also occur in exclusively breastfed infants, although this is rare. Both immediate (IgE mediated) and delayed (non-IgE mediated) reactions can occur, with CMPA usually used to describe immediate reactions and CMPI for mild-moderate delayed reactions. Symptoms of CMPI/CMPA include regurgitation and vomiting, diarrhea, urticaria, atopic eczema, colic symptoms such as irritability and crying, wheezing, chronic cough, and rarely, angioedema and anaphylaxis.

Diagnosis of CMPI/CMPA is often based on clinical presentation, such as improvement with cow’s milk protein elimination. However, investigations such as skin prick/patch testing and total IgE and specific IgE (RAST) for cow’s milk protein may also be performed. If symptoms are severe, such as failure to thrive, referral to a pediatrician is necessary.

Management of CMPI/CMPA depends on whether the child is formula-fed or breastfed. For formula-fed infants with mild-moderate symptoms, extensively hydrolyzed formula (eHF) milk is the first-line replacement formula, while amino acid-based formula (AAF) is used for infants with severe CMPA or if there is no response to eHF. Around 10% of infants with CMPI/CMPA are also intolerant to soy milk. For breastfed infants, mothers should continue breastfeeding while eliminating cow’s milk protein from their diet. Calcium supplements may be prescribed to prevent deficiency while excluding dairy from the diet. When breastfeeding stops, eHF milk should be used until the child is at least 12 months old and for at least 6 months.

The prognosis for CMPI/CMPA is generally good, with most children eventually becoming milk tolerant. In children with IgE-mediated intolerance, around 55% will be milk tolerant by the age of 5 years, while in children with non-IgE mediated intolerance, most will be milk tolerant by the age of 3 years. However, a challenge is often performed in a hospital setting as anaphylaxis can occur.

Recommended Vaccinations for Adolescents

A booster vaccination for tetanus and diphtheria is required for adolescents between the ages of 14 and 16. It is recommended that these boosters be administered every 10 years thereafter. In some countries, a second dose of the MMR vaccine is given at age 12. The BCG vaccine is not routinely given, but is offered to individuals who are at risk. It is important for adolescents to stay up-to-date on their vaccinations to protect themselves and those around them from preventable diseases.

If a child under the age of 3 months has a fever exceeding 38ºC, they should be considered at high risk for serious illness according to the NICE traffic light system. This is classified as a red alert. NICE CKS provides additional information, stating that research from six studies indicates that the risk of serious illness is more than 10 times greater in this age group compared to older children.

The NICE Feverish illness in children guidelines were introduced in 2007 and updated in 2013 to provide a ‘traffic light’ system for assessing the risk of febrile illness in children under 5 years old. The guidelines recommend recording the child’s temperature, heart rate, respiratory rate, and capillary refill time, as well as looking for signs of dehydration. Measuring temperature should be done with an electronic thermometer in the axilla for children under 4 weeks or with an electronic/chemical dot thermometer in the axilla or an infra-red tympanic thermometer. The risk stratification table categorizes children as green (low risk), amber (intermediate risk), or red (high risk) based on their symptoms. Management recommendations vary depending on the risk level, with green children managed at home, amber children provided with a safety net or referred to a specialist, and red children urgently referred to a specialist. The guidelines also advise against prescribing oral antibiotics without an apparent source of fever and note that a chest x-ray is not necessary if a child with suspected pneumonia is not being referred to the hospital.

Guidelines for Safe Immunisation

Immunisation is an important aspect of public health, and the Department of Health has published guidelines to ensure its safe administration. The guidelines, titled ‘Immunisation against infectious disease’, outline general contraindications to immunisation, situations where vaccines should be delayed, and specific contraindications to live vaccines.

General contraindications include confirmed anaphylactic reactions to previous doses of a vaccine containing the same antigens or to another component in the relevant vaccine, such as egg protein. Vaccines should also be delayed in cases of febrile illness or intercurrent infection.

Live vaccines should not be administered to pregnant women or individuals with immunosuppression. In the case of the DTP vaccine, vaccination should be deferred in children with an evolving or unstable neurological condition.

However, there are several situations where immunisation is not contraindicated. These include asthma or eczema, a history of seizures (unless associated with fever), being breastfed, a previous history of natural infection with pertussis, measles, mumps, or rubella, a history of neonatal jaundice, a family history of autism, neurological conditions such as Down’s or cerebral palsy, low birth weight or prematurity, and patients on replacement steroids.

Overall, these guidelines aim to ensure the safe administration of vaccines and protect individuals from infectious diseases.